Pre-transplantation immunological monitoring and graft survival in recipients of renal allografts.
Various immunological parameters were measured pre-transplantation in 82 renal transplant recipients. The results were compared with the clinical course of the recipient post-transplantation and with the results of 40 controls. Only one test C3 inactivation products (C3i) was associated with transplant outcome in that 0/30 patients with no rejection episodes had C3i whereas 9/38 patients with rejection episodes, including 3/12 patients whose graft failed, had C3i.
D000328:Adult; D000368:Aged; D002464:Cell Migration Inhibition; D003165:Complement System Proteins / Q000032:analysis; D005260:Female; D006085:Graft Survival; D006801:Humans; D007111:Immunity, Cellular; D007136:Immunoglobulins / Q000032:analysis; D016030:Kidney Transplantation; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D008875:Middle Aged; D008934:Mitogens / Q000494:pharmacology; D008991:Monitoring, Physiologic / Q000379:methods*; D011300:Preoperative Care; D011379:Prognosis; D012397:Rosette Formation; D012882:Skin Tests
D007136:Immunoglobulins; D008934:Mitogens; D003165:Complement System Proteins